Fructooligosacharides	O
Reduce	O
Pseudomonas	B-OG
aeruginosa	I-OG
PAO1	I-OG
Pathogenicity	O
through	O
Distinct	O
Mechanisms	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
MG	O
OMA	O
DA	O
.	O

Performed	O
the	O
experiments	O
:	O
OMA	O
FSM	O
TK	O
DA	O
.	O

Analyzed	O
the	O
data	O
:	O
DA	O
OMA	O
TK	O
FSM	O
.	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
CM	O
RP	O
DP	O
DA	O
.	O

Wrote	O
the	O
paper	O
:	O
FSM	O
OMA	O
TK	O
DA	O
.	O

Pseudomonas	B-OG
aeruginosa	I-OG
is	O
ubiquitously	O
present	O
in	O
the	O
environment	O
and	O
acts	O
as	O
an	O
opportunistic	O
pathogen	O
on	O
humans	B-OG
,	O
animals	B-OG
and	O
plants	B-OG
.	O

We	O
report	O
here	O
the	O
effects	O
of	O
the	O
prebiotic	O
polysaccharide	O
inulin	O
and	O
its	O
hydrolysed	O
form	O
FOS	O
on	O
this	O
bacterium	B-OG
.	O

FOS	O
was	O
found	O
to	O
inhibit	O
bacterial	O
growth	O
of	O
strain	O
PAO1	B-OG
,	O
while	O
inulin	O
did	O
not	O
affect	O
growth	O
rate	O
or	O
yield	O
in	O
a	O
significant	O
manner	O
.	O

Inulin	O
stimulated	O
biofilm	O
formation	O
,	O
whereas	O
a	O
dramatic	O
reduction	O
of	O
the	O
biofilm	O
formation	O
was	O
observed	O
in	O
the	O
presence	O
of	O
FOS	O
.	O

Similar	O
opposing	O
effects	O
were	O
observed	O
for	O
bacterial	O
motility	O
,	O
where	O
FOS	O
inhibited	O
the	O
swarming	O
and	O
twitching	O
behaviour	O
whereas	O
inulin	O
caused	O
its	O
stimulation	O
.	O

In	O
co	O
-	O
cultures	O
with	O
eukaryotic	O
cells	O
(	O
macrophages	O
)	O
FOS	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
inulin	O
reduced	O
the	O
secretion	O
of	O
the	O
inflammatory	B-GP
cytokines	I-GP
IL	B-GP
-	I-GP
6	I-GP
,	O
IL	B-GP
-	I-GP
10	I-GP
and	O
TNF	B-GP
-	I-GP
α	I-GP
.	O

Western	O
blot	O
experiments	O
indicated	O
that	O
the	O
effects	O
mediated	O
by	O
FOS	O
in	O
macrophages	O
are	O
associated	O
with	O
a	O
decreased	O
activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
pathway	O
.	O

Since	O
FOS	O
and	O
inulin	O
stimulate	O
pathway	O
activation	O
in	O
the	O
absence	O
of	O
bacteria	B-OG
,	O
the	O
FOS	O
mediated	O
effect	O
is	O
likely	O
to	O
be	O
of	O
indirect	O
nature	O
,	O
such	O
as	O
via	O
a	O
reduction	O
of	O
bacterial	O
virulence	O
.	O

Further	O
,	O
this	O
modulatory	O
effect	O
is	O
observed	O
also	O
with	O
the	O
highly	O
virulent	O
ptxS	B-GP
mutated	O
strain	O
.	O

Co	O
-	O
culture	O
experiments	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
with	O
IEC18	O
eukaryotic	O
cells	O
showed	O
that	O
FOS	O
reduces	O
the	O
concentration	O
of	O
the	O
major	O
virulence	O
factor	O
,	O
exotoxin	B-GP
A	I-GP
,	O
suggesting	O
that	O
this	O
is	O
a	O
possible	O
mechanism	O
for	O
the	O
reduction	O
of	O
pathogenicity	O
.	O

The	O
potential	O
of	O
these	O
compounds	O
as	O
components	O
of	O
antibacterial	O
and	O
anti	O
-	O
inflammatory	O
cocktails	O
is	O
discussed	O
.	O

Introduction	O

Strains	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
are	O
ubiquitously	O
present	O
in	O
the	O
environment	O
[	O
1	O
],	O
which	O
is	O
due	O
to	O
their	O
capacity	O
to	O
colonize	O
different	O
ecological	O
niches	O
[	O
2	O
],	O
[	O
3	O
]	O
and	O
metabolic	O
versatility	O
[	O
4	O
].	O
P	B-OG
.	I-OG
aeruginosa	I-OG
is	O
an	O
opportunistic	O
pathogen	O
able	O
to	O
infect	O
different	O
animals	B-OG
and	O
plants	B-OG
[	O
5	O
],	O
[	O
6	O
],	O
being	O
a	O
frequent	O
cause	O
of	O
hospital	B-DS
-	I-DS
acquired	I-DS
infections	I-DS
including	O
ventilator	B-DS
associated	I-DS
pneumonia	I-DS
[	O
7	O
]	O
and	O
catheter	B-DS
infections	I-DS
in	O
immuno	O
-	O
compromised	O
patients	O
.	O
P	B-DS
.	I-DS
aeruginosa	I-DS
lung	I-DS
infections	I-DS
are	O
the	O
main	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
cystic	B-DS
fibrosis	I-DS
(	O
CF	B-DS
)	O
patients	O
[	O
8	O
].	O

The	O
bacterium	B-OG
is	O
highly	O
resistant	O
to	O
antibiotic	O
treatment	O
and	O
difficult	O
to	O
eradicate	O
once	O
established	O
in	O
the	O
host	O
[	O
9	O
].	O

One	O
of	O
the	O
important	O
antibiotic	O
resistance	O
mechanisms	O
is	O
the	O
formation	O
of	O
biofilms	O
[	O
10	O
],	O
hence	O
a	O
great	O
deal	O
of	O
attention	O
has	O
been	O
given	O
to	O
the	O
study	O
of	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
its	O
generation	O
,	O
maturation	O
and	O
dispersal	O
[	O
11	O
],	O
[	O
12	O
].	O

It	O
has	O
been	O
shown	O
that	O
flagella	O
and	O
type	O
IV	O
pili	O
-	O
mediated	O
motility	O
are	O
required	O
for	O
efficient	O
biofilm	O
formation	O
[	O
13	O
]–[	O
15	O
].	O

Bacteria	B-OG
use	O
different	O
secretion	O
systems	O
to	O
inject	O
virulence	O
factors	O
into	O
the	O
cytoplasm	O
of	O
eukaryotic	O
cells	O
,	O
leading	O
to	O
bacterial	O
replication	O
within	O
macrophages	O
and	O
,	O
consequently	O
,	O
evasion	O
from	O
the	O
immune	O
system	O
[	O
16	O
].	O

In	O
Gram	B-OG
-	I-OG
negative	I-OG
bacteria	I-OG
several	O
secretion	O
systems	O
have	O
been	O
characterized	O
,	O
referred	O
to	O
as	O
type	O
I	O
to	O
type	O
VI	O
systems	O
[	O
17	O
],	O
[	O
18	O
].	O

The	O
type	O
II	O
(	O
T2SS	O
)	O
and	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
secrete	O
the	O
majority	O
of	O
known	O
toxins	O
[	O
19	O
].	O

They	O
differ	O
in	O
their	O
molecular	O
mechanisms	O
and	O
operate	O
on	O
several	O
substrates	O
.	O

The	O
secretion	O
system	O
type	O
I	O
is	O
an	O
ABC	B-GP
transporter	I-GP
composed	O
of	O
an	O
ABC	B-GP
protein	I-GP
,	O
a	O
membrane	B-GP
fusion	I-GP
protein	I-GP
and	O
an	O
outer	B-GP
membrane	I-GP
protein	I-GP
.	O

This	O
system	O
transports	O
various	O
molecules	O
of	O
diverse	O
nature	O
such	O
as	O
ions	O
,	O
drugs	O
,	O
and	O
proteins	O
[	O
20	O
].	O

Similarly	O
,	O
type	O
II	O
and	O
V	O
secretion	O
systems	O
generally	O
transport	O
proteins	O
to	O
the	O
surface	O
of	O
the	O
host	O
cell	O
and	O
are	O
involved	O
in	O
the	O
extracellular	O
release	O
of	O
various	O
toxins	O
and	O
hydrolytic	O
enzymes	O
such	O
as	O
exotoxin	B-GP
A	I-GP
,	O
Las	B-GP
A	I-GP
,	O
Las	B-GP
B	I-GP
,	O
protease	B-GP
and	O
elastase	B-GP
[	O
21	O
],	O
[	O
22	O
].	O

In	O
contrast	O
,	O
the	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
injects	O
proteins	O
,	O
small	O
molecular	O
weight	O
compounds	O
and	O
hydrolytic	O
enzymes	O
into	O
the	O
cytosol	O
of	O
eukaryotic	O
cells	O
[	O
23	O
],	O
which	O
corresponds	O
to	O
a	O
potent	O
virulence	O
mechanism	O
shared	O
by	O
many	O
pathogenic	O
Gram	B-OG
-	I-OG
negative	I-OG
bacteria	I-OG
.	O

This	O
protein	O
injection	O
in	O
turn	O
triggers	O
a	O
cytoskeletal	O
reorganization	O
of	O
the	O
host	O
cell	O
as	O
shown	O
by	O
the	O
inhibition	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
internalization	O
upon	O
incubation	O
with	O
cytochalasin	O
D	O
[	O
24	O
],	O
which	O
destroys	O
microfilaments	O
,	O
thereby	O
preventing	O
further	O
uptake	O
of	O
bacteria	B-OG
[	O
16	O
],	O
[	O
23	O
],	O
[	O
25	O
].	O

A	O
significant	O
number	O
of	O
natural	O
compounds	O
have	O
been	O
found	O
to	O
inhibit	O
bacterial	O
growth	O
,	O
although	O
their	O
mechanism	O
of	O
action	O
remains	O
unclear	O
in	O
most	O
cases	O
[	O
26	O
],	O
[	O
27	O
].	O

Here	O
we	O
report	O
a	O
study	O
on	O
the	O
activity	O
of	O
the	O
fructo	O
-	O
oligosaccharides	O
(	O
FOS	O
)	O
and	O
inulin	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
proliferation	O
.	O

Inulin	O
is	O
a	O
linear	O
polymer	O
formed	O
by	O
20	O
to	O
over	O
60	O
β	O
-	O
2	O
,	O
1	O
-	O
linked	O
fructose	O
monomers	O
with	O
a	O
terminal	O
glucose	O
residue	O
,	O
whereas	O
FOS	O
are	O
short	O
-	O
chain	O
oligosaccharides	O
with	O
the	O
same	O
structure	O
but	O
a	O
maximal	O
chain	O
length	O
of	O
2	O
to	O
20	O
monomeric	O
units	O
which	O
are	O
generated	O
by	O
hydrolysis	O
of	O
inulin	O
[	O
28	O
].	O

Inulin	O
is	O
found	O
in	O
different	O
nutrients	O
such	O
as	O
wheat	B-OG
,	O
onion	B-OG
,	O
garlic	B-OG
and	O
banana	B-OG
[	O
29	O
].	O

Inulin	O
and	O
FOS	O
are	O
considered	O
prebiotics	O
,	O
based	O
on	O
the	O
observation	O
that	O
they	O
promote	O
the	O
growth	O
of	O
certain	O
beneficial	O
gut	O
bacteria	B-OG
such	O
as	O
bifidobacteria	B-OG
[	O
30	O
],	O
[	O
31	O
],	O
but	O
they	O
have	O
been	O
also	O
found	O
to	O
inhibit	O
the	O
growth	O
of	O
pathogenic	O
bacteria	B-OG
such	O
as	O
Salmonella	B-OG
typhimurium	I-OG
[	O
32	O
],	O
S	O
.	O
enteritidis	O
[	O
33	O
]	O
Listeria	B-OG
monocytogenes	I-OG
or	O
the	O
fungus	B-OG
Candida	B-OG
albicans	I-OG
[	O
34	O
].	O

In	O
addition	O
inulin	O
and	O
FOS	O
have	O
been	O
found	O
to	O
have	O
a	O
beneficial	O
impact	O
on	O
human	B-OG
health	O
,	O
including	O
the	O
stimulation	O
of	O
calcium	O
,	O
iron	O
and	O
zinc	O
absorption	O
[	O
35	O
]	O
and	O
the	O
modulation	O
of	O
local	O
and	O
systemic	O
immune	O
responses	O
[	O
36	O
].	O

Here	O
we	O
show	O
that	O
the	O
addition	O
of	O
FOS	O
to	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
cultures	O
decreases	O
growth	O
and	O
biofilm	O
formation	O
.	O

This	O
effect	O
appears	O
to	O
be	O
specific	O
for	O
FOS	O
since	O
it	O
was	O
not	O
observed	O
following	O
inulin	O
treatment	O
.	O

In	O
addition	O
,	O
FOS	O
reduces	O
the	O
cytokine	B-GP
response	O
of	O
rat	B-OG
primary	O
monocytes	O
to	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infection	I-DS
,	O
an	O
effect	O
considered	O
indirect	O
since	O
this	O
oligosaccharide	O
was	O
found	O
to	O
activate	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
pathway	O
.	O

Attenuated	O
responses	O
are	O
observed	O
also	O
with	O
the	O
virulent	O
ptxS	B-GP
mutant	O
strain	O
.	O

Exotoxin	B-GP
A	I-GP
production	O
is	O
lowered	O
by	O
FOS	O
treatment	O
,	O
suggesting	O
that	O
FOS	O
may	O
interfere	O
with	O
exotoxin	O
synthesis	O
and	O
/	O
or	O
secretion	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
FOS	O
may	O
be	O
a	O
useful	O
component	O
of	O
drug	O
cocktails	O
for	O
the	O
treatment	O
of	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infections	I-DS
.	O

Results	O

Differential	O
effect	O
of	O
FOS	O
and	O
inulin	O
on	O
the	O
growth	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG

As	O
stated	O
in	O
the	O
introduction	O
,	O
a	O
number	O
of	O
natural	O
compounds	O
can	O
either	O
promote	O
or	O
slow	O
down	O
the	O
growth	O
of	O
microorganisms	O
.	O

To	O
assess	O
the	O
effect	O
of	O
inulin	O
and	O
FOS	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
,	O
growth	O
curves	O
were	O
recorded	O
in	O
minimal	O
medium	O
M9	O
supplemented	O
with	O
citrate	O
.	O

Under	O
these	O
conditions	O
only	O
minor	O
changes	O
in	O
the	O
bacterial	O
growth	O
rate	O
and	O
yield	O
were	O
observed	O
in	O
the	O
presence	O
of	O
5	O
–	O
20	O
mg	O
/	O
ml	O
inulin	O
.	O

Namely	O
,	O
5	O
and	O
15	O
mg	O
/	O
ml	O
of	O
inulin	O
resulted	O
in	O
a	O
slight	O
to	O
moderate	O
stimulation	O
of	O
growth	O
,	O
whereas	O
at	O
the	O
concentration	O
of	O
20	O
mg	O
/	O
ml	O
a	O
slight	O
reduction	O
was	O
noted	O
(	O
Fig	O
.	O
1A	O
).	O

Effect	O
of	O
inulin	O
and	O
FOS	O
on	O
the	O
growth	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
.	O

Growth	O
curves	O
in	O
minimal	O
medium	O
M9	O
supplemented	O
with	O
50	O
(	O
A	O
)	O
and	O
FOS	O
(	O
B	O
)	O
are	O
shown	O
.	O

As	O
a	O
control	O
,	O
growth	O
in	O
the	O
minimal	O
medium	O
M9	O
supplemented	O
with	O
20	O
mg	O
/	O
ml	O
of	O
goat	B-OG
milk	O
oligosaccharides	O
(	O
OS	O
)	O
is	O
shown	O
.	O

Growth	O
curves	O
were	O
recorded	O
at	O
37	O
°	O
C	O
for	O
24	O
hours	O
.	O

Representative	O
data	O
from	O
one	O
of	O
three	O
independent	O
experiments	O
with	O
similar	O
results	O
are	O
shown	O
.	O

Similarly	O
,	O
in	O
the	O
presence	O
of	O
5	O
–	O
15	O
mg	O
/	O
ml	O
of	O
FOS	O
a	O
minor	O
stimulation	O
of	O
bacterial	O
growth	O
was	O
noted	O
(	O
Fig	O
.	O
1B	O
);	O
however	O
,	O
at	O
the	O
concentration	O
of	O
20	O
mg	O
/	O
ml	O
a	O
marked	O
inhibition	O
was	O
observed	O
(	O
Fig	O
.	O
1B	O
).	O

Since	O
inulin	O
and	O
FOS	O
differ	O
only	O
in	O
the	O
carbohydrate	O
chain	O
length	O
,	O
this	O
parameter	O
appears	O
to	O
be	O
central	O
for	O
antibacterial	O
activity	O
.	O

In	O
comparison	O
,	O
a	O
growth	O
curve	O
was	O
recorded	O
in	O
the	O
presence	O
of	O
20	O
mg	O
/	O
ml	O
of	O
control	O
goat	B-OG
milk	O
oligosaccharides	O
(	O
OS	O
),	O
showing	O
promotion	O
of	O
bacterial	O
growth	O
at	O
the	O
same	O
concentration	O
at	O
which	O
FOS	O
inhibits	O
growth	O
.	O

In	O
fact	O
,	O
both	O
FOS	O
and	O
inulin	O
(	O
at	O
15	O
–	O
20	O
mg	O
/	O
ml	O
)	O
are	O
able	O
to	O
support	O
bacterial	O
growth	O
when	O
M9	O
minimal	O
medium	O
is	O
used	O
(	O
data	O
not	O
shown	O
).	O

Reduction	O
of	O
biofilm	O
formation	O
in	O
the	O
presence	O
of	O
FOS	O

To	O
assess	O
the	O
influence	O
of	O
FOS	O
and	O
inulin	O
on	O
biofilm	O
formation	O
,	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
was	O
cultured	O
in	O
24	O
-	O
well	O
plates	O
in	O
the	O
absence	O
or	O
presence	O
of	O
different	O
concentrations	O
of	O
both	O
compounds	O
for	O
6	O
hours	O
(	O
Fig	O
.	O
2A	O
),	O
followed	O
by	O
a	O
quantification	O
of	O
biofilm	O
formation	O
.	O
Fig	O
.	O
2	O
B	O
and	O
Fig	O
.	O

S1	O
show	O
the	O
relative	O
amount	O
of	O
biofilm	O
formation	O
as	O
a	O
function	O
of	O
the	O
inulin	O
/	O
FOS	O
concentration	O
(	O
logarithmic	O
scale	O
).	O

It	O
became	O
apparent	O
that	O
both	O
compounds	O
have	O
opposite	O
effects	O
;	O
whereas	O
inulin	O
stimulated	O
biofilm	O
formation	O
,	O
FOS	O
had	O
a	O
concentration	O
dependent	O
inhibitory	O
effect	O
.	O

Fitting	O
of	O
data	O
(	O
Fig	O
.	O
2B	O
)	O
resulted	O
in	O
an	O
EC50	O
value	O
of	O
2	O
.	O
1	O
mg	O
/	O
ml	O
for	O
FOS	O
(	O
inhibition	O
)	O
and	O
5	O
.	O
8	O
mg	O
/	O
ml	O
for	O
inulin	O
(	O
stimulation	O
).	O

Biofilm	O
formation	O
was	O
almost	O
completely	O
inhibited	O
at	O
a	O
FOS	O
concentration	O
of	O
4	O
–	O
8	O
mg	O
/	O
ml	O
,	O
which	O
is	O
in	O
sharp	O
contrast	O
with	O
inulin	O
that	O
produced	O
a	O
∼	O
10	O
-	O
fold	O
enhancement	O
at	O
concentrations	O
up	O
to	O
approximately	O
10	O
mg	O
/	O
ml	O
.	O

Formation	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
biofilm	O
.	O

A	O
)	O
Biofilm	O
formation	O
in	O
the	O
absence	O
and	O
presence	O
of	O
different	O
concentrations	O
of	O
FOS	O
and	O
inulin	O
in	O
24	O
-	O
well	O
plates	O
.	O

Biofilm	O
formation	O
was	O
monitored	O
in	O
M9	O
minimal	O
medium	O
supplemented	O
with	O
0	O
.	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
glucose	O
and	O
casamino	O
acids	O
and	O
quantified	O
after	O
6	O
h	O
.	O

B	O
)	O
The	O
relative	O
amounts	O
of	O
biofilm	O
formation	O
in	O
the	O
experiments	O
shown	O
in	O
Fig	O
.	O
2A	O
are	O
plotted	O
against	O
the	O
logarithm	O
of	O
inulin	O
/	O
FOS	O
concentration	O
.	O

Data	O
were	O
fitted	O
with	O
the	O
sigmoidal	O
model	O
of	O
the	O
ORIGIN	O
software	O
package	O
to	O
determine	O
EC50	O
values	O
.	O

Data	O
are	O
the	O
average	O
of	O
three	O
independent	O
assays	O
.	O

C	O
)	O
Microscopic	O
inspection	O
of	O
biofilm	O
formation	O
in	O
the	O
absence	O
and	O
in	O
the	O
presence	O
of	O
20	O
mg	O
/	O
ml	O
inulin	O
or	O
FOS	O
at	O
2	O
,	O
4	O
and	O
6	O
hours	O
.	O

Subsequently	O
,	O
biofilms	O
formed	O
in	O
the	O
presence	O
or	O
absence	O
of	O
both	O
compounds	O
(	O
at	O
20	O
mg	O
/	O
ml	O
)	O
were	O
observed	O
under	O
the	O
microscope	O
(	O
Fig	O
.	O
2C	O
).	O

To	O
this	O
end	O
bacteria	B-OG
were	O
grown	O
in	O
M9	O
minimal	O
medium	O
supplemented	O
with	O
0	O
.	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
glucose	O
,	O
0	O
.	O
4	O
%	O
(	O
wt	O
/	O
v	O
)	O
casamino	O
acids	O
and	O
with	O
inulin	O
or	O
FOS	O
.	O

In	O
control	O
conditions	O
clear	O
biofilm	O
formation	O
was	O
observed	O
after	O
4	O
and	O
6	O
hours	O
of	O
culture	O
,	O
as	O
expected	O
(	O
Fig	O
.	O
2C	O
).	O

Similar	O
results	O
were	O
obtained	O
with	O
20	O
mg	O
/	O
ml	O
of	O
inulin	O
,	O
but	O
the	O
biofilm	O
was	O
more	O
prominent	O
after	O
6	O
h	O
as	O
compared	O
to	O
the	O
control	O
sample	O
.	O

In	O
contrast	O
,	O
while	O
biofilm	O
formation	O
in	O
the	O
presence	O
of	O
FOS	O
was	O
comparable	O
to	O
that	O
in	O
control	O
conditions	O
after	O
4	O
hours	O
,	O
it	O
was	O
virtually	O
absent	O
at	O
6	O
h	O
(	O
Fig	O
.	O
2C	O
).	O

FOS	O
and	O
inulin	O
have	O
opposite	O
effects	O
on	O
bacterial	O
motility	O

P	B-OG
.	I-OG
aeruginosa	I-OG
has	O
been	O
shown	O
to	O
exhibit	O
three	O
different	O
types	O
of	O
motility	O
,	O
namely	O
swimming	O
,	O
swarming	O
and	O
twitching	O
[	O
37	O
],	O
[	O
38	O
].	O

Twitching	O
motility	O
across	O
solid	O
surfaces	O
[	O
39	O
]	O
has	O
been	O
found	O
to	O
be	O
required	O
for	O
biofilm	O
development	O
[	O
13	O
],	O
[	O
40	O
],	O
as	O
well	O
as	O
for	O
a	O
persistent	O
colonization	O
of	O
lungs	O
,	O
and	O
it	O
is	O
associated	O
with	O
virulence	O
in	O
corneal	B-DS
infection	I-DS
models	O
[	O
39	O
],	O
[	O
41	O
].	O

We	O
have	O
studied	O
the	O
effect	O
of	O
inulin	O
and	O
FOS	O
at	O
5	O
mg	O
/	O
ml	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
bacterial	O
motility	O
on	O
agar	O
plates	O
and	O
in	O
bacterial	O
suspension	O
(	O
Fig	O
.	O
3	O
).	O

Neither	O
FOS	O
nor	O
inulin	O
affected	O
swimming	O
behaviour	O
(	O
Fig	O
.	O
3A	O
).	O

Interestingly	O
,	O
FOS	O
inhibited	O
both	O
swarming	O
and	O
twitching	O
motility	O
,	O
whereas	O
inulin	O
treatment	O
resulted	O
in	O
the	O
opposite	O
effect	O
,	O
i	O
.	O
e	O
.	O
stimulation	O
(	O
Fig	O
.	O
3B	O
and	O
C	O
).	O

Effects	O
of	O
FOS	O
and	O
inulin	O
on	O
the	O
motility	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
.	O

Motility	O
assays	O
were	O
carried	O
out	O
as	O
described	O
in	O
materials	O
and	O
methods	O
.	O

Inulin	O
or	O
FOS	O
at	O
5	O
mg	O
/	O
ml	O
was	O
present	O
in	O
the	O
agar	O
plates	O
and	O
in	O
the	O
bacterial	O
suspensions	O
.	O

A	O
)	O
Swimming	O
assays	O
.	O

B	O
)	O
Swarming	O
assays	O
and	O
C	O
)	O
Twitching	O
assays	O
.	O

Average	O
values	O
of	O
the	O
distances	O
of	O
bacterial	O
migration	O
are	O
shown	O
.	O

Data	O
are	O
the	O
average	O
of	O
three	O
independent	O
assays	O
.	O

Values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.,	O
n	O
=	O
6	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
without	O
effectors	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

Inulin	O
and	O
FOS	O
reduce	O
cytokine	B-GP
secretion	O
in	O
P	B-OG
.	I-OG
aeruginosa	I-OG
infected	O
macrophages	O

Tissue	B-DS
injury	I-DS
or	O
infection	B-DS
results	O
in	O
the	O
recruitment	O
and	O
activation	O
of	O
host	O
immune	O
cells	O
.	O

Macrophages	O
are	O
the	O
first	O
immune	O
cells	O
likely	O
to	O
encounter	O
P	B-OG
.	I-OG
aeruginosa	I-OG
.	O

The	O
activation	O
of	O
macrophages	O
is	O
based	O
largely	O
on	O
the	O
recognition	O
of	O
pathogens	O
by	O
molecular	O
pattern	O
receptors	O
,	O
including	O
Toll	B-GP
-	I-GP
like	I-GP
receptors	I-GP
(	O
TLRs	B-GP
),	O
such	O
as	O
TLR4	B-GP
[	O
16	O
],	O
[	O
42	O
].	O

Macrophages	O
can	O
internalize	O
and	O
kill	O
bacterial	O
pathogens	O
;	O
however	O
,	O
during	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infections	I-DS
their	O
role	O
in	O
pathogen	O
sensing	O
is	O
of	O
primary	O
importance	O
[	O
43	O
].	O

This	O
in	O
turn	O
causes	O
significant	O
changes	O
in	O
gene	O
expression	O
and	O
the	O
secretion	O
of	O
proinflammatory	B-GP
cytokines	I-GP
IL	B-GP
-	I-GP
6	I-GP
and	O
TNF	B-GP
-	I-GP
α	I-GP
that	O
recruit	O
inflammatory	O
cells	O
in	O
response	O
to	O
bacterial	O
virulence	O
factors	O
,	O
while	O
IL	B-GP
-	I-GP
10	I-GP
tends	O
to	O
mitigate	O
this	O
response	O
[	O
44	O
]–[	O
47	O
].	O

These	O
are	O
among	O
the	O
main	O
signalling	O
mediators	O
released	O
by	O
monocyte	O
/	O
macrophages	O
.	O

Initial	O
experiments	O
were	O
carried	O
out	O
to	O
establish	O
the	O
experimental	O
conditions	O
for	O
the	O
assessment	O
of	O
the	O
effect	O
of	O
FOS	O
and	O
inulin	O
on	O
cytokine	B-GP
secretion	O
(	O
Fig	O
.	O

S2	O
).	O

Macrophages	O
were	O
incubated	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
and	O
interleukin	B-GP
6	I-GP
secretion	O
was	O
measured	O
at	O
different	O
time	O
intervals	O
(	O
Fig	O
.	O

S2	O
).	O

Maximal	O
secretion	O
was	O
observed	O
after	O
4	O
hours	O
of	O
incubation	O
.	O

Therefore	O
,	O
these	O
experimental	O
conditions	O
were	O
used	O
to	O
quantify	O
the	O
effect	O
of	O
FOS	O
/	O
inulin	O
on	O
the	O
secretion	O
of	O
IL	B-GP
-	I-GP
6	I-GP
,	O
IL	B-GP
-	I-GP
10	I-GP
and	O
TNF	B-GP
-	I-GP
α	I-GP
.	O

In	O
the	O
absence	O
of	O
bacteria	B-OG
(	O
Fig	O
.	O
4	O
,	O
column	O
–	O
PAO1	B-OG
),	O
inulin	O
and	O
FOS	O
had	O
no	O
significant	O
effect	O
on	O
cytokine	B-GP
secretion	O
,	O
although	O
a	O
slight	O
increase	O
was	O
noted	O
.	O

PAO	B-DS
-	I-DS
1	I-DS
infection	I-DS
caused	O
the	O
expected	O
significant	O
increase	O
in	O
cytokine	B-GP
secretion	O
.	O

This	O
response	O
was	O
markedly	O
attenuated	O
for	O
the	O
three	O
cytokines	B-GP
in	O
the	O
presence	O
of	O
FOS	O
,	O
while	O
inulin	O
caused	O
exclusively	O
a	O
reduction	O
in	O
IL	B-GP
-	I-GP
6	I-GP
levels	O
(	O
Fig	O
.	O
4	O
).	O

These	O
data	O
therefore	O
show	O
that	O
the	O
presence	O
of	O
inulin	O
and	O
particularly	O
FOS	O
reduced	O
the	O
inflammatory	O
response	O
of	O
macrophages	O
to	O
bacterial	B-DS
infection	I-DS
.	O

Since	O
FOS	O
/	O
inulin	O
did	O
not	O
reduce	O
the	O
cytokine	B-GP
release	O
in	O
the	O
absence	O
of	O
bacteria	B-OG
,	O
our	O
results	O
suggest	O
that	O
the	O
inhibitory	O
effect	O
of	O
FOS	O
is	O
probably	O
due	O
to	O
a	O
direct	O
interaction	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
.	O

Effect	O
of	O
inulin	O
and	O
FOS	O
on	O
inflammatory	O
response	O
of	O
macrophages	O
against	O
P	B-OG
.	I-OG
aeruginosa	I-OG
(	O
WT	O
).	O

Macrophages	O
were	O
incubated	O
with	O
WT	O
P	B-OG
.	I-OG
aeruginosa	I-OG
cells	O
(	O
ratio	O
1	O
/	O
5	O
)	O
for	O
4	O
hours	O
in	O
either	O
the	O
absence	O
or	O
the	O
presence	O
of	O
5	O
mg	O
/	O
ml	O
FOS	O
and	O
inulin	O
prior	O
to	O
the	O
determination	O
of	O
IL	B-GP
-	I-GP
6	I-GP
(	O
A	O
),	O
IL	B-GP
-	I-GP
10	I-GP
(	O
B	O
)	O
and	O
TNF	B-GP
-	I-GP
α	I-GP
secretion	O
(	O
C	O
).	O

Values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.,	O
n	O
=	O
6	O
–	O
8	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
without	O
bacteria	B-OG
and	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
WT	O
in	O
the	O
absence	O
of	O
inulin	O
or	O
FOS	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

Activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
signal	O
transduction	O
pathway	O
is	O
downregulated	O
by	O
FOS	O

The	O
mitogen	B-GP
-	I-GP
activated	I-GP
protein	I-GP
kinase	I-GP
(	O
MAPK	B-GP
)	O
and	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
signalling	O
pathways	O
are	O
implicated	O
in	O
the	O
production	O
of	O
TNF	B-GP
-	I-GP
α	I-GP
and	O
IL	B-GP
-	I-GP
6	I-GP
in	O
macrophages	O
[	O
48	O
].	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infection	I-DS
is	O
associated	O
to	O
stimulation	O
of	O
TLR4	B-GP
receptors	O
,	O
leading	O
to	O
an	O
activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
pathway	O
[	O
49	O
].	O

To	O
assess	O
the	O
impact	O
of	O
inulin	O
and	O
FOS	O
on	O
the	O
inflammatory	O
response	O
,	O
the	O
role	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
and	O
MAPK	B-GP
signalling	O
pathways	O
in	O
the	O
FOS	O
-	O
mediated	O
modulation	O
of	O
macrophages	O
was	O
assessed	O
.	O

One	O
of	O
the	O
ways	O
to	O
activate	O
NF	B-GP
-	I-GP
κB	I-GP
by	O
extracellular	O
stimuli	O
involves	O
the	O
rapid	O
degradation	O
of	O
IκB	B-GP
-	I-GP
α	I-GP
as	O
a	O
consequence	O
of	O
IκB	B-GP
-	I-GP
α	I-GP
phosphorylation	O
at	O
Ser32	O
by	O
IκB	B-GP
kinase	I-GP
,	O
which	O
corresponds	O
to	O
IKK	B-GP
in	O
the	O
so	O
-	O
called	O
canonical	O
pathway	O
.	O

We	O
studied	O
the	O
effect	O
of	O
inulin	O
and	O
FOS	O
on	O
the	O
activation	O
(	O
phosphorylation	O
)	O
of	O
IκB	B-GP
-	I-GP
α	I-GP
and	O
MAPK	B-GP
,	O
ERK	B-GP
,	O
JNK	B-GP
and	O
p38	B-GP
by	O
Western	O
blot	O
analysis	O
in	O
macrophages	O
infected	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
.	O

As	O
shown	O
in	O
Fig	O
.	O
5A	O
,	O
neither	O
FOS	O
nor	O
inulin	O
affected	O
the	O
phosphospecific	O
signal	O
of	O
the	O
three	O
MAPK	B-GP
,	O
suggesting	O
that	O
they	O
are	O
not	O
involved	O
in	O
the	O
observed	O
changes	O
.	O

In	O
contrast	O
,	O
FOS	O
but	O
not	O
inulin	O
reduced	O
IκB	B-GP
-	I-GP
α	I-GP
phosphorylation	O
,	O
pointing	O
to	O
a	O
modulation	O
of	O
the	O
NFκ	O
-	O
B	O
canonical	O
pathway	O
.	O

FOS	O
but	O
not	O
inulin	O
reduces	O
the	O
amount	O
of	O
phosphorylated	O
IkB	B-GP
-	I-GP
α	I-GP
.	O

A	O
)	O
Macrophages	O
were	O
infected	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
in	O
the	O
absence	O
or	O
presence	O
of	O
either	O
5	O
mg	O
/	O
ml	O
FOS	O
or	O
inulin	O
.	O

After	O
4	O
h	O
growth	O
Western	O
blots	O
were	O
performed	O
using	O
cell	O
extracts	O
and	O
the	O
corresponding	O
antibodies	O
against	O
ERK	B-GP
(	O
Extracellular	B-GP
Regulated	I-GP
Kinase	I-GP
),	O
p	O
-	O
ERK	B-GP
(	O
the	O
phosphorylated	O
form	O
of	O
Extracellular	B-GP
Regulated	I-GP
Kinase	I-GP
),	O
p	O
-	O
P38	B-GP
(	O
activated	O
and	O
phosphorylated	O
form	O
of	O
P38	B-GP
mitogen	I-GP
-	I-GP
activated	I-GP
protein	I-GP
kinases	I-GP
),	O
p	O
-	O
JNK	B-GP
(	O
Jun	B-GP
N	I-GP
-	I-GP
terminal	I-GP
kinases	I-GP
)	O
and	O
after	O
1	O
h	O
for	O
p	O
-	O
IκB	B-GP
-	I-GP
α	I-GP
(	O
activated	O
form	O
in	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
canonical	O
pathway	O
).	O

As	O
control	O
,	O
actin	B-GP
was	O
quantified	O
in	O
all	O
samples	O
using	O
an	O
anti	O
-	O
α	B-GP
-	I-GP
actin	I-GP
antibody	O
.	O

Duplicate	O
samples	O
in	O
the	O
absence	O
of	O
added	O
effectors	O
and	O
triplicate	O
samples	O
in	O
the	O
presence	O
of	O
FOS	O
and	O
inulin	O
are	O
shown	O
.	O

B	O
)	O
NF	B-GP
-	I-GP
κB	I-GP
activation	O
was	O
determined	O
by	O
measuring	O
the	O
nuclear	O
translocation	O
of	O
the	O
p65	B-GP
component	O
,	O
expressed	O
as	O
the	O
OD450	O
nm	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
without	O
bacteria	B-OG
and	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
WT	O
in	O
the	O
absence	O
of	O
inulin	O
or	O
FOS	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

Moreover	O
,	O
the	O
activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
transcription	O
factor	O
is	O
associated	O
with	O
the	O
nuclear	O
translocation	O
of	O
the	O
p65	B-GP
component	O
of	O
the	O
complex	O
.	O

To	O
confirm	O
the	O
effect	O
of	O
inulin	O
or	O
FOS	O
on	O
nuclear	O
NF	B-GP
-	I-GP
κB	I-GP
/	O
p65	B-GP
translocation	O
,	O
p65	B-GP
was	O
quantified	O
by	O
ELISA	O
in	O
cell	O
nuclei	O
following	O
1	O
h	O
activation	O
.	O

In	O
contrast	O
to	O
inulin	O
,	O
FOS	O
(	O
5	O
mg	O
/	O
ml	O
)	O
effectively	O
reduced	O
NF	B-GP
-	I-GP
κB	I-GP
/	O
p65	B-GP
translocation	O
(	O
Fig	O
.	O
5B	O
).	O

Therefore	O
,	O
the	O
effect	O
of	O
FOS	O
is	O
associated	O
with	O
a	O
minor	O
activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
signalling	O
pathway	O
.	O

The	O
effect	O
of	O
FOS	O
is	O
observed	O
in	O
P	B-OG
.	I-OG
aeruginosa	I-OG
mutant	O
strains	O
with	O
different	O
degrees	O
of	O
virulence	O

Since	O
the	O
FOS	O
-	O
mediated	O
inhibition	O
of	O
bacterial	O
growth	O
and	O
biofilm	O
formation	O
may	O
reduce	O
virulence	O
,	O
we	O
hypothesized	O
that	O
the	O
response	O
of	O
eukaryotic	O
cells	O
to	O
infection	B-DS
may	O
be	O
modulated	O
by	O
the	O
presence	O
of	O
this	O
oligosaccharide	O
.	O

Subsequent	O
experiments	O
were	O
aimed	O
at	O
assessing	O
the	O
effect	O
of	O
FOS	O
and	O
inulin	O
in	O
two	O
strains	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
showing	O
different	O
levels	O
of	O
virulence	O
compared	O
as	O
compared	O
to	O
wild	O
type	O
strain	O
.	O

We	O
used	O
mutants	O
deficient	O
in	O
PtxS	B-GP
and	O
PtxR	B-GP
,	O
two	O
transcriptional	B-GP
regulators	I-GP
that	O
control	O
the	O
expression	O
of	O
the	O
toxA	B-GP
gene	O
,	O
encoding	O
the	O
exotoxin	B-GP
A	I-GP
virulence	O
factor	O
[	O
50	O
].	O

Both	O
,	O
PtxR	B-GP
and	O
PtxS	B-GP
play	O
a	O
role	O
in	O
regulating	O
the	O
activity	O
from	O
the	O
PtoxA	O
promoter	O
[	O
51	O
].	O

Mutation	O
of	O
ptxS	B-GP
increases	O
toxA	B-GP
expression	O
by	O
a	O
factor	O
of	O
∼	O
4	O
,	O
whereas	O
deletion	O
of	O
ptxR	B-GP
causes	O
a	O
∼	O
2	O
-	O
fold	O
reduction	O
[	O
51	O
].	O

The	O
increase	O
in	O
toxicity	O
of	O
the	O
ptxS	B-GP
mutant	O
(	O
Fig	O
.	O
6A	O
)	O
is	O
reflected	O
in	O
the	O
colour	O
of	O
bacterial	O
cultures	O
due	O
to	O
the	O
increased	O
production	O
of	O
the	O
bright	O
blue	O
-	O
green	O
siderophore	O
pyocyanin	O
,	O
an	O
important	O
virulence	O
factor	O
of	O
fluorescent	B-OG
Pseudomonads	I-OG
[	O
52	O
]–[	O
54	O
].	O

In	O
contrast	O
the	O
colour	O
of	O
the	O
ptxR	B-GP
mutant	O
is	O
similar	O
to	O
that	O
of	O
the	O
wild	O
type	O
strain	O
.	O

Further	O
,	O
anti	O
-	O
exotoxin	B-GP
A	I-GP
western	O
blot	O
showed	O
that	O
ptxS	B-GP
mutant	O
produces	O
significantly	O
more	O
exotoxin	B-GP
A	I-GP
than	O
the	O
ptxR	B-GP
mutant	O
(	O
Fig	O
.	O
6B	O
).	O

Subsequently	O
,	O
the	O
cytotoxic	O
activity	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
on	O
macrophages	O
was	O
analysed	O
4	O
hours	O
after	O
infection	B-DS
,	O
using	O
the	O
Cytotox	O
96	O
®	O
non	O
-	O
radioactive	O
cytotoxicity	O
assay	O
kit	O
.	O

As	O
expected	O
,	O
cytotoxicity	O
was	O
highest	O
for	O
the	O
ptxS	B-GP
mutant	O
(	O
Fig	O
.	O
6C	O
)	O
where	O
approximately	O
25	O
%	O
of	O
cells	O
died	O
,	O
followed	O
by	O
the	O
wild	O
type	O
strain	O
(	O
10	O
%	O
of	O
cell	O
death	O
)	O
and	O
the	O
ptxR	B-GP
mutant	O
for	O
which	O
no	O
toxicity	O
was	O
detected	O
(	O
Figure	O
6C	O
).	O

The	O
lactase	B-GP
dehydrogenase	I-GP
(	O
LDH	B-GP
)	O
is	O
a	O
marker	O
for	O
cytotoxicity	O
.	O

We	O
have	O
determined	O
the	O
LDH	B-GP
levels	O
of	O
0	O
.	O
1	O
–	O
0	O
.	O
2	O
mU	O
/	O
µl	O
in	O
the	O
absence	O
of	O
bacteria	B-OG
but	O
in	O
the	O
presence	O
of	O
FOS	O
or	O
inulin	O
(	O
data	O
not	O
shown	O
).	O

Both	O
compounds	O
did	O
not	O
induce	O
any	O
significant	O
changes	O
in	O
the	O
LDH	B-GP
levels	O
,	O
indicating	O
that	O
they	O
are	O
not	O
cytotoxic	O
to	O
macrophages	O
under	O
the	O
conditions	O
used	O
(	O
data	O
not	O
shown	O
).	O

Effect	O
of	O
wild	O
type	O
and	O
mutant	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
on	O
macrophages	O
.	O

A	O
)	O
Cultures	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
and	O
its	O
mutants	O
deficient	O
in	O
ptxS	B-GP
and	O
ptxR	B-GP
were	O
grown	O
in	O
M9	O
Minimum	O
medium	O
supplemented	O
with	O
50	O
mM	O
citrate	O
for	O
24	O
hours	O
.	O

The	O
blue	O
-	O
green	O
colour	O
is	O
indicative	O
of	O
an	O
increased	O
pyocyanin	O
secretion	O
.	O

B	O
)	O
Western	O
blot	O
determination	O
of	O
exotoxin	B-GP
A	I-GP
concentration	O
secreted	O
by	O
P	B-OG
.	I-OG
aeruginosa	I-OG
WT	O
and	O
its	O
isogenic	O
mutants	O
ptxS	B-GP
and	O
ptxR	B-GP
.	O

C	O
)	O
The	O
macrophage	O
mortality	O
induced	O
by	O
WT	O
P	B-OG
.	I-OG
aeruginosa	I-OG
and	O
its	O
ptxS	B-GP
and	O
ptxR	B-GP
mutants	O
was	O
measured	O
by	O
the	O
total	O
release	O
of	O
cytoplasmic	O
lactate	B-GP
dehydrogenase	I-GP
(	O
LDH	B-GP
).	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
without	O
bacteria	B-OG
and	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
with	O
WT	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

As	O
expected	O
,	O
the	O
cytokine	B-GP
secretory	O
response	O
followed	O
the	O
same	O
pattern	O
,	O
being	O
higher	O
with	O
the	O
ptxS	B-GP
mutant	O
,	O
followed	O
by	O
the	O
wild	O
type	O
and	O
lower	O
for	O
the	O
ptxR	B-GP
mutant	O
(	O
Fig	O
.	O
7	O
)	O
(	O
Data	O
from	O
Fig	O
.	O
4	O
are	O
included	O
for	O
comparison	O
)	O
[	O
51	O
].	O

For	O
all	O
three	O
bacterial	O
strains	O
analysed	O
,	O
FOS	O
caused	O
a	O
very	O
pronounced	O
reduction	O
(	O
Fig	O
.	O
7	O
),	O
while	O
inulin	O
caused	O
a	O
more	O
moderate	O
reduction	O
.	O

Interestingly	O
,	O
the	O
FOS	O
/	O
inulin	O
mediated	O
reduction	O
was	O
more	O
pronounced	O
in	O
the	O
ptxS	B-GP
mutant	O
than	O
in	O
WT	O
strain	O
,	O
suggesting	O
that	O
virulent	O
strains	O
may	O
be	O
more	O
sensitive	O
to	O
the	O
effect	O
of	O
fructose	O
oligosaccharides	O
.	O

Effect	O
of	O
inulin	O
and	O
FOS	O
on	O
inflammatory	O
response	O
of	O
macrophages	O
against	O
WT	O
P	B-OG
.	I-OG
aeruginosa	I-OG
and	O
its	O
isogenic	O
mutants	O
ptxS	B-GP
and	O
ptxR	B-GP
.	O

Macrophages	O
were	O
incubated	O
with	O
WT	O
and	O
mutant	O
P	B-OG
.	I-OG
aeruginosa	I-OG
cells	O
(	O
ratio	O
1	O
/	O
5	O
)	O
for	O
4	O
hours	O
in	O
either	O
the	O
absence	O
or	O
the	O
presence	O
of	O
5	O
mg	O
/	O
ml	O
FOS	O
and	O
inulin	O
prior	O
to	O
the	O
determination	O
of	O
IL	B-GP
-	I-GP
6	I-GP
(	O
A	O
),	O
IL	B-GP
-	I-GP
10	I-GP
(	O
B	O
)	O
and	O
TNF	B-GP
-	I-GP
α	I-GP
secretion	O
(	O
C	O
).	O

Values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.,	O
n	O
=	O
6	O
–	O
8	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
WT	O
in	O
the	O
absence	O
of	O
inulin	O
or	O
FOS	O
;	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
ptxS	B-GP
mutant	O
without	O
effectors	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

P	B-OG
.	I-OG
aeruginosa	I-OG
employs	O
a	O
number	O
of	O
systems	O
to	O
secrete	O
proteins	O
which	O
play	O
different	O
roles	O
during	O
infection	B-DS
.	O

To	O
analyse	O
the	O
role	O
of	O
FOS	O
or	O
inulin	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
virulence	O
,	O
exotoxin	B-GP
A	I-GP
was	O
quantified	O
in	O
supernatants	O
of	O
bacterial	O
co	O
-	O
cultures	O
with	O
eukaryotic	O
cells	O
as	O
well	O
as	O
within	O
eukaryotic	O
cells	O
.	O

To	O
achieve	O
a	O
good	O
separation	O
of	O
eukaryotic	O
cells	O
from	O
bacteria	B-OG
,	O
we	O
used	O
the	O
rat	B-OG
small	O
intestinal	O
cell	O
line	O
IEC18	O
that	O
grows	O
on	O
surfaces	O
and	O
exhibits	O
inflammatory	O
responses	O
[	O
55	O
],	O
[	O
56	O
].	O

Bacteria	B-OG
are	O
removed	O
by	O
a	O
washing	O
step	O
with	O
fresh	O
PBS	O
solution	O
,	O
leaving	O
an	O
intact	O
IEC18	O
cell	O
monolayer	O
containing	O
infecting	O
Pseudomonas	B-OG
.	O

Anti	O
-	O
exotoxin	B-GP
A	I-GP
western	O
blot	O
analysis	O
showed	O
that	O
the	O
addition	O
of	O
FOS	O
and	O
inulin	O
to	O
eukaryotic	O
cells	O
did	O
not	O
alter	O
exotoxin	B-GP
A	I-GP
levels	O
present	O
in	O
the	O
culture	O
medium	O
(	O
data	O
not	O
shown	O
).	O

In	O
contrast	O
,	O
FOS	O
was	O
found	O
to	O
reduce	O
intracellular	O
exotoxin	B-GP
A	I-GP
levels	O
in	O
IEC18	O
cells	O
co	O
-	O
cultured	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
,	O
whereas	O
no	O
significant	O
change	O
was	O
observed	O
in	O
the	O
presence	O
of	O
inulin	O
(	O
Fig	O
.	O
8A	O
and	O
B	O
).	O

These	O
data	O
suggest	O
that	O
the	O
type	O
II	O
-	O
dependent	O
exotoxin	B-GP
A	I-GP
secretion	O
from	O
P	B-OG
.	I-OG
aeruginosa	I-OG
to	O
the	O
cell	O
cytosol	O
is	O
inhibited	O
by	O
FOS	O
,	O
presumably	O
limiting	O
its	O
virulence	O
.	O

Because	O
we	O
cannot	O
rule	O
out	O
the	O
presence	O
of	O
extracellular	O
,	O
cell	O
adherent	O
bacteria	B-OG
in	O
the	O
sample	O
,	O
it	O
may	O
be	O
possible	O
that	O
FOS	O
also	O
downregulates	O
exotoxin	B-GP
A	I-GP
in	O
extracellular	O
Pseudomonas	B-OG
.	O

FOS	O
reduces	O
exotoxin	B-GP
A	I-GP
expression	O
.	O

A	O
)	O
Western	O
blot	O
determination	O
of	O
the	O
cellular	O
concentration	O
of	O
exotoxin	B-GP
A	I-GP
in	O
IEC18	O
cells	O
following	O
co	O
-	O
culture	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
in	O
the	O
presence	O
and	O
absence	O
of	O
FOS	O
and	O
inulin	O
.	O

B	O
)	O
Densitometric	O
analysis	O
of	O
above	O
data	O
.	O

Exotoxin	B-GP
A	I-GP
densities	O
were	O
corrected	O
with	O
those	O
obtained	O
for	O
α	B-GP
-	I-GP
actin	I-GP
.	O

Values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.,	O
n	O
=	O
3	O
;	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
/	O
WT	O
without	O
inulin	O
or	O
FOS	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

Discussion	O

Prebiotics	O
are	O
defined	O
as	O
compounds	O
that	O
have	O
beneficial	O
effects	O
on	O
humans	B-OG
by	O
altering	O
the	O
intestinal	O
microbiota	O
in	O
a	O
manner	O
that	O
is	O
beneficial	O
to	O
health	O
.	O

The	O
mechanism	O
of	O
their	O
action	O
is	O
not	O
clear	O
,	O
but	O
it	O
is	O
thought	O
to	O
involve	O
preferential	O
utilization	O
of	O
oligosaccharides	O
by	O
host	O
-	O
friendly	O
bacterial	O
species	O
such	O
as	O
bifidobacteria	B-OG
or	O
lactobacilli	B-OG
,	O
indicating	O
that	O
prebiotic	O
substances	O
might	O
have	O
the	O
capacity	O
to	O
protect	O
against	O
infections	O
and	O
reduce	O
the	O
presence	O
of	O
clinically	O
relevant	O
pathogens	O
in	O
the	O
faecal	O
flora	O
[	O
57	O
],	O
[	O
58	O
].	O

Another	O
proposed	O
mechanism	O
involves	O
enhanced	O
bacteriocin	B-GP
secretion	O
by	O
lactobacilli	B-OG
[	O
59	O
],	O
which	O
in	O
turn	O
facilitates	O
the	O
incorporation	O
of	O
bacteria	B-OG
into	O
a	O
niche	O
and	O
inhibits	O
the	O
invasion	O
of	O
competing	O
strains	O
or	O
pathogens	O
,	O
leading	O
ultimately	O
to	O
a	O
modulation	O
of	O
the	O
microbiota	O
and	O
of	O
the	O
host	O
immune	O
system	O
.	O

Therefore	O
,	O
the	O
inhibition	O
of	O
pathogens	O
by	O
prebiotics	O
is	O
thought	O
to	O
be	O
largely	O
due	O
to	O
indirect	O
effects	O
[	O
60	O
].	O

However	O
,	O
antimicrobial	O
properties	O
have	O
been	O
described	O
for	O
a	O
number	O
of	O
oligosaccharides	O
[	O
61	O
].	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
showing	O
that	O
FOS	O
,	O
one	O
of	O
the	O
most	O
studied	O
and	O
used	O
prebiotics	O
,	O
has	O
specific	O
effects	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
.	O

We	O
were	O
able	O
to	O
show	O
that	O
FOS	O
(	O
1	O
)	O
inhibits	O
P	B-OG
.	I-OG
aeruginosa	I-OG
growth	O
,	O
biofilm	O
formation	O
and	O
motility	O
;	O
(	O
2	O
)	O
limits	O
the	O
P	B-OG
.	I-OG
aeruginosa	I-OG
evoked	O
NF	B-GP
-	I-GP
κB	I-GP
dependent	O
cytokine	B-GP
secretion	O
in	O
macrophages	O
;	O
and	O
(	O
3	O
)	O
decreases	O
exotoxin	B-GP
A	I-GP
levels	O
in	O
P	B-OG
.	I-OG
aeruginosa	I-OG
infected	O
IEC18	O
cells	O
.	O

These	O
effects	O
have	O
also	O
been	O
observed	O
for	O
inulin	O
,	O
but	O
in	O
general	O
the	O
magnitude	O
of	O
the	O
changes	O
induced	O
by	O
FOS	O
was	O
superior	O
to	O
that	O
of	O
inulin	O
.	O

This	O
indicates	O
that	O
the	O
length	O
of	O
the	O
oligosaccharide	O
chains	O
is	O
an	O
essential	O
determinant	O
for	O
the	O
magnitude	O
of	O
the	O
biological	O
activities	O
observed	O
.	O

This	O
is	O
exemplified	O
by	O
growth	O
inhibition	O
:	O
both	O
FOS	O
and	O
inulin	O
can	O
be	O
used	O
as	O
carbon	O
and	O
energy	O
source	O
by	O
P	B-OG
.	I-OG
aeruginosa	I-OG
and	O
it	O
is	O
therefore	O
not	O
surprising	O
to	O
see	O
a	O
growth	O
stimulation	O
in	O
the	O
presence	O
of	O
up	O
to	O
10	O
mg	O
/	O
ml	O
of	O
both	O
compounds	O
(	O
Fig	O
.	O
1	O
and	O
data	O
not	O
shown	O
).	O

However	O
,	O
at	O
a	O
concentration	O
of	O
20	O
mg	O
/	O
ml	O
inulin	O
had	O
a	O
very	O
modest	O
effect	O
on	O
growth	O
which	O
contrasts	O
with	O
FOS	O
that	O
caused	O
a	O
very	O
significant	O
growth	O
inhibition	O
.	O

These	O
results	O
are	O
consistent	O
with	O
a	O
biphasic	O
response	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
to	O
FOS	O
/	O
inulin	O
:	O
growth	O
is	O
stimulated	O
at	O
low	O
concentrations	O
of	O
inulin	O
and	O
then	O
inhibited	O
to	O
a	O
certain	O
extent	O
;	O
the	O
same	O
response	O
is	O
observed	O
with	O
FOS	O
,	O
but	O
growth	O
inhibition	O
is	O
clearly	O
more	O
pronounced	O
.	O

The	O
control	O
goat	B-OG
milk	O
oligosaccharides	O
did	O
not	O
produce	O
any	O
inhibition	O
at	O
similar	O
concentrations	O
,	O
underlining	O
the	O
specificity	O
of	O
action	O
of	O
FOS	O
.	O

The	O
variety	O
of	O
cellular	O
processes	O
modulated	O
by	O
FOS	O
was	O
a	O
surprising	O
finding	O
and	O
it	O
is	O
tempting	O
to	O
speculate	O
that	O
glycoside	B-GP
receptors	I-GP
may	O
be	O
involved	O
in	O
the	O
recognition	O
of	O
FOS	O
and	O
that	O
these	O
receptors	O
signal	O
via	O
different	O
cascades	O
modulating	O
different	O
cellular	O
processes	O
.	O

Such	O
a	O
mechanism	O
would	O
be	O
comparable	O
to	O
that	O
for	O
the	O
sensing	O
of	O
other	O
antimicrobial	O
glycosides	O
[	O
62	O
].	O

Otherwise	O
,	O
biofilm	O
formation	O
is	O
a	O
major	O
mechanism	O
that	O
confers	O
bacterial	O
resistance	O
and	O
biofilm	O
induced	O
antibiotics	O
tolerance	O
is	O
of	O
major	O
clinical	O
importance	O
[	O
63	O
].	O

Currently	O
significant	O
research	O
efforts	O
are	O
being	O
made	O
to	O
identify	O
compounds	O
that	O
interfere	O
with	O
biofilm	O
formation	O
,	O
maturation	O
and	O
dispersion	O
and	O
to	O
explore	O
their	O
effect	O
in	O
infection	B-DS
models	O
[	O
64	O
].	O

Here	O
we	O
show	O
that	O
FOS	O
and	O
inulin	O
have	O
opposite	O
effects	O
on	O
biofilm	O
formation	O
.	O

While	O
inulin	O
caused	O
a	O
stimulation	O
,	O
a	O
dramatic	O
reduction	O
was	O
observed	O
in	O
the	O
presence	O
of	O
FOS	O
(	O
Fig	O
.	O
2	O
and	O
Fig	O
.	O

S1	O
).	O

Interestingly	O
,	O
FOS	O
did	O
not	O
appear	O
to	O
affect	O
the	O
early	O
stages	O
of	O
biofilm	O
formation	O
since	O
no	O
significant	O
changes	O
were	O
observed	O
after	O
4	O
hours	O
growth	O
(	O
Fig	O
.	O
2C	O
).	O

In	O
turn	O
,	O
a	O
dramatic	O
reduction	O
was	O
seen	O
after	O
6	O
hours	O
(	O
Fig	O
.	O
2C	O
),	O
suggesting	O
that	O
FOS	O
interferes	O
with	O
later	O
stages	O
of	O
biofilm	O
formation	O
or	O
triggers	O
its	O
dispersal	O
.	O

Further	O
experiments	O
to	O
elucidate	O
this	O
point	O
are	O
underway	O
.	O

We	O
hypothesized	O
that	O
these	O
effects	O
may	O
alter	O
P	B-OG
.	I-OG
aeruginosa	I-OG
virulence	O
.	O

In	O
order	O
to	O
test	O
this	O
hypothesis	O
,	O
we	O
infected	O
rat	B-OG
primary	O
monocyte	O
cultures	O
with	O
PAO1	B-OG
and	O
measured	O
cytokine	B-GP
release	O
in	O
the	O
presence	O
and	O
absence	O
of	O
oligosaccharides	O
.	O

Monocytes	O
display	O
an	O
enhanced	O
release	O
of	O
cytokines	B-GP
in	O
response	O
to	O
infection	B-DS
,	O
which	O
was	O
shown	O
to	O
be	O
chiefly	O
dependent	O
on	O
NF	B-GP
-	I-GP
κB	I-GP
activation	O
and	O
p65	B-GP
nuclear	O
translocation	O
.	O

These	O
are	O
early	O
changes	O
associated	O
with	O
modest	O
cytotoxicity	O
due	O
to	O
the	O
short	O
incubation	O
time	O
.	O

Remarkably	O
,	O
treatment	O
with	O
FOS	O
attenuated	O
significantly	O
all	O
the	O
steps	O
of	O
this	O
response	O
,	O
i	O
.	O
e	O
.	O
secretion	O
of	O
IL	B-GP
-	I-GP
6	I-GP
,	O
IL	B-GP
-	I-GP
10	I-GP
and	O
TNF	B-GP
-	I-GP
α	I-GP
,	O
IκB	B-GP
-	I-GP
α	I-GP
phosphorylation	O
and	O
p65	B-GP
nuclear	O
translocation	O
(	O
Figs	O
.	O

4	O
and	O
5	O
).	O

Inulin	O
in	O
contrast	O
had	O
a	O
significantly	O
more	O
moderate	O
effect	O
.	O

In	O
the	O
absence	O
of	O
bacteria	B-OG
neither	O
FOS	O
nor	O
inulin	O
caused	O
an	O
effect	O
on	O
cytokine	B-GP
secretion	O
and	O
their	O
long	O
-	O
term	O
effect	O
on	O
macrophages	O
(	O
and	O
intestinal	O
epithelial	O
cells	O
)	O
is	O
an	O
activation	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
pathway	O
[	O
65	O
]	O
and	O
thus	O
contrary	O
to	O
the	O
oligosaccharide	O
reduction	O
of	O
pathway	O
activity	O
.	O

Thus	O
it	O
follows	O
that	O
the	O
inhibited	O
NF	B-GP
-	I-GP
κB	I-GP
response	O
in	O
this	O
case	O
is	O
likely	O
to	O
be	O
of	O
indirect	O
nature	O
,	O
i	O
.	O
e	O
.	O
borne	O
out	O
of	O
a	O
reduced	O
stimulation	O
by	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infection	I-DS
,	O
confirming	O
our	O
hypothesis	O
.	O

This	O
may	O
also	O
explain	O
why	O
inulin	O
failed	O
to	O
inhibit	O
IκB	B-GP
-	I-GP
α	I-GP
phosphorylation	O
,	O
since	O
it	O
is	O
also	O
capable	O
of	O
activating	O
this	O
signalling	O
pathway	O
;	O
however	O
,	O
it	O
is	O
unclear	O
why	O
inulin	O
decreases	O
IL	B-GP
-	I-GP
6	I-GP
and	O
IL	B-GP
-	I-GP
10	I-GP
secretion	O
.	O

Our	O
data	O
suggest	O
that	O
MAPK	B-GP
is	O
not	O
involved	O
in	O
this	O
process	O
.	O

We	O
then	O
investigated	O
potential	O
links	O
between	O
FOS	O
and	O
other	O
determinants	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
virulence	O
,	O
such	O
as	O
the	O
PtxS	B-GP
and	O
PtxR	B-GP
regulators	O
that	O
modulate	O
exotoxin	B-GP
A	I-GP
expression	O
(	O
Fig	O
.	O
6B	O
).	O

Mutation	O
of	O
the	O
corresponding	O
genes	O
showed	O
the	O
expected	O
alterations	O
in	O
cytokine	B-GP
release	O
and	O
cytotoxicity	O
in	O
infected	O
monocytes	O
,	O
respectively	O
,	O
confirming	O
previous	O
observations	O
[	O
51	O
].	O

These	O
changes	O
correlated	O
with	O
toxA	B-GP
expression	O
,	O
since	O
the	O
highest	O
cytokine	B-GP
secretion	O
/	O
toxA	B-GP
transcription	O
was	O
observed	O
in	O
the	O
ptxS	B-GP
mutant	O
,	O
followed	O
by	O
the	O
WT	O
strain	O
and	O
the	O
ptxR	B-GP
mutant	O
[	O
51	O
].	O

It	O
is	O
therefore	O
likely	O
that	O
exotoxin	B-GP
A	I-GP
plays	O
a	O
role	O
in	O
stimulating	O
cytokine	B-GP
secretion	O
in	O
the	O
host	O
cell	O
.	O

The	O
main	O
finding	O
of	O
this	O
series	O
of	O
experiments	O
is	O
that	O
FOS	O
exerts	O
its	O
modulatory	O
effects	O
also	O
on	O
the	O
more	O
virulent	O
ptxS	B-GP
mutant	O
.	O

Of	O
note	O
,	O
the	O
effect	O
of	O
inulin	O
was	O
somewhat	O
increased	O
compared	O
to	O
that	O
on	O
the	O
wild	O
type	O
,	O
although	O
always	O
lower	O
than	O
that	O
of	O
FOS	O
.	O

Our	O
results	O
therefore	O
suggest	O
that	O
FOS	O
effectively	O
reduces	O
the	O
virulence	O
of	O
3	O
different	O
strains	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
.	O

Modulation	O
of	O
exotoxin	B-GP
A	I-GP
expression	O
or	O
transport	O
can	O
probably	O
be	O
associated	O
with	O
this	O
effect	O
.	O

P	B-OG
.	I-OG
aeruginosa	I-OG
is	O
an	O
opportunistic	O
pathogen	O
and	O
can	O
infect	O
immunocompromised	O
individuals	O
at	O
different	O
sites	O
such	O
as	O
the	O
respiratory	O
tract	O
,	O
intestine	O
,	O
skin	O
,	O
urinary	O
tract	O
,	O
and	O
wounds	O
.	O

The	O
severity	O
of	O
the	O
opportunistic	B-DS
infection	I-DS
depends	O
to	O
a	O
great	O
extent	O
on	O
the	O
virulence	O
factors	O
expressed	O
by	O
the	O
bacterium	B-OG
,	O
which	O
in	O
turn	O
influence	O
cytotoxicity	O
and	O
antibiotic	O
resistance	O
.	O

As	O
a	O
result	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infections	I-DS
are	O
notoriously	O
difficult	O
to	O
treat	O
.	O

Several	O
classes	O
of	O
antibiotics	O
including	O
cephalosporins	O
,	O
penicillins	O
,	O
carbapenems	O
,	O
quinolones	O
and	O
aminoglycosides	O
are	O
currently	O
been	O
used	O
to	O
combat	O
P	B-OG
.	I-OG
aeruginosa	I-OG
clinically	O
,	O
but	O
specific	O
sensitivity	O
testing	O
is	O
mandatory	O
[	O
66	O
].	O

Our	O
data	O
suggest	O
that	O
FOS	O
may	O
be	O
a	O
useful	O
component	O
of	O
a	O
drug	O
cocktail	O
to	O
combat	O
P	B-DS
.	I-DS
aeruginosa	I-DS
infection	I-DS
.	O

Alternatively	O
,	O
it	O
appears	O
also	O
plausible	O
to	O
use	O
FOS	O
in	O
a	O
prophylactic	O
context	O
to	O
prevent	O
gastrointestinal	B-DS
infections	I-DS
.	O

Oral	O
FOS	O
supplements	O
are	O
currently	O
been	O
used	O
to	O
prevent	O
gastrointestinal	B-DS
infections	I-DS
[	O
67	O
],	O
which	O
implies	O
that	O
the	O
oral	O
route	O
may	O
be	O
also	O
valid	O
to	O
administer	O
FOS	O
to	O
fight	O
Pseudomonas	B-OG
infection	B-DS
.	O

However	O
,	O
any	O
clinical	O
application	O
will	O
require	O
an	O
extensive	O
study	O
of	O
the	O
potential	O
effects	O
of	O
FOS	O
on	O
the	O
human	B-OG
body	O
which	O
are	O
issues	O
that	O
are	O
to	O
be	O
addressed	O
in	O
the	O
future	O
.	O

Materials	O
and	O
Methods	O

Animals	B-OG

Wistar	B-OG
rats	I-OG
(	O
200	O
–	O
250	O
g	O
)	O
obtained	O
from	O
the	O
Animal	O
Service	O
Laboratory	O
of	O
the	O
University	O
of	O
Granada	O
(	O
Spain	O
)	O
were	O
used	O
,	O
housed	O
in	O
macrolon	O
cages	O
,	O
and	O
maintained	O
in	O
air	O
-	O
conditioned	O
animal	O
quarters	O
with	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
.	O

Rats	B-OG
were	O
given	O
free	O
access	O
to	O
tap	O
water	O
and	O
food	O
.	O

This	O
study	O
was	O
carried	O
out	O
in	O
accordance	O
with	O
the	O
Directive	O
for	O
the	O
Protection	O
of	O
Vertebrate	O
Animals	B-OG
used	O
for	O
Experimental	O
and	O
other	O
Scientific	O
Purposes	O
of	O
the	O
European	O
Union	O
(	O
86	O
/	O
609	O
/	O
EEC	O
)	O
and	O
the	O
animal	O
protocol	O
used	O
has	O
been	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
the	O
Granada	O
University	O
.	O

Bacterial	O
strains	O
used	O
in	O
this	O
study	O

P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
and	O
its	O
mutants	O
deficient	O
in	O
ptxS	B-GP
and	O
ptxR	B-GP
obtained	O
through	O
insertion	O
of	O
streptomycin	O
and	O
tetracycline	O
cassettes	O
,	O
respectively	O
[	O
51	O
],	O
were	O
grown	O
in	O
LB	O
medium	O
or	O
M9	O
minimal	O
medium	O
(	O
Na2HPO4	O
:	O
6	O
g	O
/	O
l	O
;	O
KH2PO4	O
:	O
3	O
g	O
/	O
l	O
;	O
NaCl	O
:	O
0	O
.	O
5	O
g	O
/	O
l	O
;	O
NH4Cl	O
:	O
1	O
g	O
/	O
l	O
,	O
1	O
mM	O
MgSO4	O
,	O
0	O
.	O
3	O
mM	O
CaCl2	O
and	O
0	O
.	O
2	O
ml	O
/	O
l	O
of	O
1	O
%	O
ferric	O
ammonium	O
citrate	O
)	O
[	O
68	O
].	O

When	O
required	O
,	O
antibiotics	O
were	O
added	O
to	O
the	O
culture	O
medium	O
to	O
reach	O
a	O
final	O
concentration	O
of	O
50	O
µg	O
/	O
ml	O
ampicillin	O
,	O
50	O
µg	O
/	O
ml	O
streptomycin	O
and	O
30	O
µg	O
/	O
ml	O
tetracycline	O
.	O

Chemicals	O

Inulin	O
and	O
FOS	O
were	O
provided	O
by	O
BENEO	O
-	O
Orafti	O
(	O
Tienen	O
,	O
Belgium	O
).	O

FOS	O
and	O
inulin	O
were	O
kindly	O
provided	O
by	O
BENEO	O
Orafti	O
®	O
(	O
Tienen	O
,	O
Belgium	O
).	O

Orafti	O
®	O
GR	O
(	O
inulin	O
)	O
is	O
a	O
food	O
ingredient	O
consisting	O
mainly	O
of	O
chicory	B-OG
root	O
inulin	O
,	O
a	O
mixture	O
of	O
oligo	O
-	O
and	O
polysaccharides	O
which	O
are	O
composed	O
of	O
fructose	O
units	O
linked	O
together	O
by	O
β	O
(	O
2	O
-	O
1	O
)	O
linkages	O
.	O

Almost	O
every	O
molecule	O
is	O
terminated	O
by	O
a	O
glucose	O
unit	O
.	O

The	O
total	O
number	O
of	O
fructose	O
or	O
glucose	O
units	O
(	O
=	O
Degree	O
of	O
Polymerization	O
or	O
DP	O
)	O
of	O
chicory	B-OG
inulin	O
ranges	O
mainly	O
between	O
2	O
and	O
60	O
.	O

Orafti	O
®	O
P95	O
oligofructose	O
(	O
FOS	O
)	O
is	O
produced	O
by	O
the	O
partial	O
enzymatic	O
hydrolysis	O
of	O
chicory	B-OG
-	O
derived	O
inulin	O
,	O
consisting	O
mainly	O
of	O
molecules	O
with	O
DP	O
between	O
2	O
and	O
8	O
.	O

Solutions	O
were	O
made	O
at	O
200	O
g	O
/	O
l	O
in	O
M9	O
minimal	O
medium	O
and	O
,	O
in	O
the	O
case	O
of	O
eukaryotic	O
cell	O
cultures	O
,	O
in	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
(	O
DMEM	O
)	O
containing	O
fetal	O
bovine	O
serum	O
(	O
10	O
%),	O
2	O
mM	O
L	O
-	O
glutamine	O
,	O
and	O
2	O
.	O
5	O
mg	O
/	O
mL	O
amphotericin	O
B	O
,	O
all	O
provided	O
by	O
Sigma	O
.	O

Solutions	O
were	O
filtered	O
using	O
0	O
.	O
22	O
µm	O
cut	O
-	O
off	O
filters	O
and	O
aliquots	O
were	O
stored	O
at	O
−	O
20	O
°	O
C	O
.	O

The	O
goat	B-OG
milk	O
oligosaccharides	O
(	O
OS	O
)	O
were	O
obtained	O
according	O
to	O
the	O
method	O
described	O
in	O
[	O
69	O
].	O

A	O
product	O
containing	O
>	O
80	O
%	O
of	O
the	O
original	O
oligosaccharide	O
content	O
,	O
only	O
5	O
%	O
(	O
w	O
/	O
w	O
)	O
of	O
lactose	O
and	O
virtually	O
salt	O
free	O
,	O
was	O
obtained	O
and	O
used	O
to	O
carry	O
out	O
all	O
the	O
experiments	O
.	O

Effects	O
of	O
inulin	O
and	O
FOS	O
on	O
P	B-OG
.	I-OG
aeruginosa	I-OG
growth	O

Individual	O
colonies	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG
were	O
picked	O
from	O
the	O
surface	O
of	O
freshly	O
grown	O
LB	O
plates	O
and	O
grown	O
overnight	O
in	O
M9	O
minimum	O
medium	O
(	O
supplemented	O
with	O
5	O
mM	O
of	O
citrate	O
)	O
at	O
37	O
°	O
C	O
.	O

The	O
overnight	O
culture	O
was	O
diluted	O
with	O
fresh	O
M9	O
minimum	O
medium	O
to	O
an	O
OD660	O
nm	O
of	O
0	O
.	O
05	O
and	O
96	O
well	O
flat	O
-	O
bottomed	O
polystyrene	O
microtiter	O
plates	O
were	O
filled	O
with	O
180	O
µl	O
of	O
this	O
cellular	O
suspension	O
.	O

Then	O
,	O
20	O
µl	O
of	O
either	O
inulin	O
or	O
FOS	O
were	O
added	O
to	O
reach	O
final	O
concentrations	O
of	O
5	O
,	O
15	O
and	O
20	O
mg	O
/	O
ml	O
.	O

Plates	O
were	O
incubated	O
at	O
37	O
°	O
C	O
under	O
continuous	O
agitation	O
in	O
a	O
Bioscreen	O
C	O
MBR	O
analyser	O
FP	O
-	O
1100	O
-	O
C	O
(	O
OY	O
Growth	O
Curves	O
Ab	O
Ltd	O
.,	O
Raisio	O
,	O
Finland	O
).	O

The	O
turbidity	O
was	O
measured	O
using	O
a	O
wideband	O
filter	O
at	O
420	O
–	O
660	O
nm	O
every	O
60	O
minutes	O
over	O
a	O
24	O
h	O
period	O
.	O

The	O
measurements	O
at	O
580	O
nm	O
were	O
used	O
to	O
generate	O
growth	O
curves	O
.	O

Some	O
cultures	O
were	O
carried	O
out	O
with	O
the	O
same	O
medium	O
without	O
citrate	O
.	O

Semiquantitative	O
determination	O
of	O
biofilm	O
formation	O

Semiquantitative	O
determination	O
of	O
biofilm	O
formation	O
was	O
performed	O
as	O
described	O
[	O
70	O
].	O

Experiments	O
were	O
conducted	O
in	O
24	O
well	O
flat	O
-	O
bottomed	O
polystyrene	O
microtiter	O
plates	O
in	O
M9	O
minimal	O
medium	O
supplemented	O
with	O
0	O
.	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
of	O
glucose	O
and	O
0	O
.	O
4	O
%	O
(	O
w	O
/	O
v	O
)	O
casamino	O
acids	O
in	O
the	O
absence	O
and	O
in	O
the	O
presence	O
of	O
different	O
concentrations	O
(	O
up	O
to	O
20	O
mg	O
/	O
ml	O
)	O
of	O
inulin	O
or	O
FOS	O
.	O

Biofilm	O
formation	O
was	O
quantified	O
after	O
6	O
h	O
by	O
staining	O
with	O
crystal	O
violet	O
following	O
the	O
method	O
described	O
in	O
[	O
71	O
].	O

The	O
structure	O
of	O
biofilms	O
was	O
observed	O
under	O
contrast	O
-	O
phase	O
microscopy	O
using	O
a	O
Zeiss	O
Axioscope	O
fluorescence	O
microscope	O
coupled	O
to	O
a	O
Nikon	O
DSS	O
-	O
Mc	O
CCD	O
camera	O
and	O
a	O
100	O
-	O
fold	O
magnifier	O
.	O

Data	O
reported	O
are	O
means	O
from	O
two	O
independent	O
experiments	O
each	O
conducted	O
in	O
quadruplet	O
repeats	O
.	O

Motility	O
assays	O

Assays	O
were	O
carried	O
out	O
to	O
determine	O
the	O
effect	O
of	O
inulin	O
and	O
FOS	O
(	O
each	O
at	O
a	O
concentration	O
of	O
5	O
mg	O
/	O
ml	O
)	O
on	O
swimming	O
,	O
twitching	O
and	O
swarming	O
.	O

In	O
all	O
assays	O
these	O
compounds	O
were	O
added	O
at	O
identical	O
concentrations	O
to	O
the	O
bacterial	O
suspension	O
in	O
the	O
plates	O
.	O

For	O
swimming	O
assays	O
bacteria	B-OG
were	O
placed	O
with	O
the	O
help	O
of	O
a	O
sterile	O
tooth	O
-	O
pick	O
at	O
the	O
centre	O
of	O
plates	O
containing	O
a	O
5	O
mm	O
layer	O
of	O
LB	O
medium	O
with	O
0	O
.	O
3	O
%	O
(	O
w	O
/	O
v	O
)	O
Bacto	O
agar	O
,	O
0	O
.	O
2	O
%	O
casamino	O
acids	O
(	O
w	O
/	O
v	O
)	O
and	O
30	O
mM	O
glucose	O
.	O

Plates	O
were	O
incubated	O
at	O
37	O
°	O
C	O
for	O
24	O
h	O
and	O
the	O
radial	O
diffusion	O
of	O
bacteria	B-OG
,	O
due	O
to	O
swimming	O
,	O
was	O
measured	O
.	O

To	O
monitor	O
twitching	O
motility	O
bacteria	B-OG
were	O
placed	O
with	O
a	O
toothpick	O
into	O
a	O
2	O
mm	O
thick	O
layer	O
containing	O
1	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
Bacto	O
agar	O
,	O
0	O
.	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
casamino	O
acids	O
and	O
30	O
mM	O
glucose	O
.	O

After	O
incubation	O
for	O
24	O
h	O
at	O
37	O
°	O
C	O
,	O
the	O
expansion	O
of	O
bacteria	B-OG
on	O
the	O
plate	O
was	O
observed	O
.	O

For	O
swarming	O
assays	O
5	O
µl	O
of	O
an	O
overnight	O
culture	O
of	O
bacteria	B-OG
were	O
placed	O
into	O
the	O
centre	O
of	O
swarm	O
plates	O
,	O
which	O
are	O
made	O
of	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
Bacto	O
agar	O
supplement	O
with	O
0	O
.	O
2	O
%	O
(	O
w	O
/	O
v	O
)	O
casamino	O
acids	O
and	O
30	O
mM	O
glucose	O
.	O

Plates	O
were	O
incubated	O
at	O
37	O
°	O
C	O
for	O
24	O
h	O
,	O
followed	O
by	O
an	O
inspection	O
of	O
the	O
bacterial	O
surface	O
movement	O
[	O
72	O
].	O

All	O
the	O
motility	O
assays	O
were	O
performed	O
in	O
triplicates	O
.	O

Macrophage	O
cell	O
isolation	O
by	O
magnetic	O
activated	O
cell	O
sorting	O

Female	O
Wistar	B-OG
rats	I-OG
were	O
sacrificed	O
by	O
cervical	O
dislocation	O
and	O
the	O
spleen	O
was	O
extracted	O
aseptically	O
.	O

Cell	O
suspensions	O
were	O
obtained	O
by	O
disrupting	O
the	O
tissues	O
between	O
dissecting	O
forceps	O
in	O
medium	O
.	O

After	O
centrifugation	O
(	O
1500	O
×	O
rpm	O
/	O
5	O
min	O
),	O
cells	O
were	O
cleared	O
of	O
erythrocytes	O
by	O
resuspension	O
in	O
hypotonic	O
lysis	O
buffer	O
(	O
15	O
mM	O
NH4Cl	O
,	O
10	O
mM	O
KHCO3	O
,	O
0	O
.	O
1	O
mM	O
Na2EDTA	O
,	O
pH	O
7	O
.	O
3	O
)	O
for	O
30	O
min	O
on	O
ice	O
.	O

Mononuclear	O
cells	O
were	O
washed	O
and	O
resuspended	O
in	O
MACs	O
buffer	O
(	O
PBS	O
containing	O
0	O
.	O
5	O
%	O
(	O
w	O
/	O
v	O
)	O
BSA	O
,	O
2	O
mM	O
EDTA	O
,	O
pH	O
7	O
.	O
2	O
).	O

To	O
obtain	O
a	O
monocellular	O
suspension	O
,	O
cells	O
were	O
passed	O
through	O
70	O
µm	O
nylon	O
mesh	O
prior	O
to	O
magnetic	O
labelling	O
and	O
subsequently	O
isolated	O
by	O
negative	O
selection	O
.	O

To	O
remove	O
lymphocytes	O
,	O
CD161	B-GP
.	O
1	O
-	O
biotin	O
(	O
1	O
∶	O
200	O
),	O
CD45RA	B-GP
-	O
PE	B-GP
(	O
1	O
∶	O
200	O
)	O
and	O
CD3	B-GP
(	O
1	O
∶	O
150	O
)	O
(	O
Biosciences	O
),	O
were	O
added	O
and	O
incubated	O
at	O
4	O
°	O
C	O
for	O
30	O
min	O
.	O

Cells	O
were	O
washed	O
and	O
sedimented	O
by	O
centrifugation	O
at	O
1500	O
×	O
rpm	O
for	O
5	O
min	O
.	O

After	O
resuspension	O
in	O
MACs	O
buffer	O
,	O
25	O
µl	O
of	O
each	O
antibiotin	O
Microbeads	O
and	O
anti	O
-	O
PE	B-GP
-	O
microbeads	O
(	O
Miltenyi	O
Biotec	O
),	O
were	O
added	O
and	O
the	O
resulting	O
suspension	O
incubated	O
at	O
4	O
°	O
C	O
during	O
30	O
min	O
.	O

Cells	O
were	O
washed	O
,	O
centrifuged	O
and	O
dissolved	O
in	O
DMEM	O
medium	O
(	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
).	O

CD161	B-GP
.	O
1	O
+,	O
CD45RA	B-GP
+	O
and	O
CD3	B-GP
+	O
cells	O
were	O
discarded	O
using	O
an	O
LD	O
column	O
(	O
Miltenyi	O
Biotec	O
).	O

Macrophages	O
in	O
the	O
flow	O
-	O
through	O
were	O
centrifuged	O
at	O
1500	O
×	O
rpm	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
(	O
DMEM	O
Sigma	O
®)	O
supplemented	O
with	O
10	O
%	O
FBS	O
(	O
sigma	O
),	O
2	O
.	O
5	O
mg	O
/	O
L	O
amphotericin	O
B	O
and	O
2	O
mM	O
L	O
-	O
glutamine	O
.	O

Measurement	O
of	O
inulin	O
-	O
and	O
FOS	O
-	O
induced	O
changes	O
in	O
cytokine	B-GP
secretion	O
from	O
macrophages	O
following	O
infection	B-DS
by	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG

For	O
the	O
determination	O
of	O
cytokine	B-GP
levels	O
the	O
macrophage	O
suspensions	O
(	O
106	O
cells	O
/	O
ml	O
DMEM	O
medium	O
)	O
were	O
co	O
-	O
cultured	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
and	O
incubated	O
with	O
5	O
mg	O
/	O
ml	O
FOS	O
or	O
inulin	O
for	O
4	O
hours	O
.	O

Following	O
centrifugation	O
at	O
4	O
°	O
C	O
and	O
10	O
.	O
000	O
×	O
rpm	O
for	O
5	O
min	O
,	O
the	O
resulting	O
supernatants	O
were	O
frozen	O
at	O
−	O
80	O
°	O
C	O
.	O

Aliquots	O
were	O
thawed	O
and	O
cytokine	B-GP
levels	O
determined	O
using	O
ELISA	O
-	O
based	O
kits	O
(	O
BD	O
Biosciences	O
,	O
Erembodegem	O
,	O
Belgium	O
)	O
following	O
the	O
protocol	O
provided	O
by	O
the	O
manufacturer	O
.	O

In	O
addition	O
,	O
macrophage	O
cells	O
were	O
used	O
for	O
the	O
quantification	O
of	O
phosphorylated	O
IκB	B-GP
-	I-GP
α	I-GP
and	O
MAP	B-GP
kinases	I-GP
by	O
Western	O
blot	O
determination	O
as	O
described	O
below	O
.	O

Western	O
blot	O

For	O
the	O
detection	O
of	O
ERK	B-GP
,	O
p	O
-	O
ERK	B-GP
,	O
p	O
-	O
P38	B-GP
,	O
p	O
-	O
JNK	B-GP
and	O
phosphorylated	O
IκB	O
-	O
P	O
,	O
cells	O
were	O
homogenized	O
in	O
lysis	O
buffer	O
(	O
PBS	O
containing	O
0	O
.	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
SDS	O
,	O
0	O
.	O
1	O
%	O
(	O
w	O
/	O
v	O
)	O
sodium	O
deoxycholate	O
,	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
Triton	O
X	O
-	O
100	O
)	O
with	O
protease	B-GP
inhibitor	O
cocktail	O
(	O
Sigma	O
)	O
1	O
∶	O
100	O
(	O
v	O
/	O
v	O
).	O

Subsequently	O
,	O
homogenates	O
were	O
sonicated	O
and	O
centrifuged	O
7000	O
×	O
g	O
for	O
5	O
min	O
at	O
4	O
°	O
C	O
.	O

Protein	O
concentrations	O
were	O
determined	O
using	O
the	O
Bicinchoninic	O
acid	O
assay	O
[	O
73	O
].	O

Samples	O
were	O
boiled	O
in	O
5	O
×	O
Laemmli	O
buffer	O
(	O
220	O
mM	O
Tris	O
,	O
312	O
µM	O
SDS	O
,	O
50	O
%	O
(	O
v	O
/	O
v	O
)	O
glycerol	O
,	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
2	O
-	O
mercaptoethanol	O
,	O
22	O
.	O
5	O
mM	O
EDTA	O
,	O
pH	O
6	O
.	O
8	O
,	O
containing	O
traces	O
of	O
bromphenol	O
blue	O
)	O
for	O
5	O
min	O
,	O
separated	O
by	O
SDS	O
-	O
PAGE	O
,	O
electroblotted	O
to	O
PVDF	O
membranes	O
(	O
Millipore	O
,	O
Madrid	O
,	O
Spain	O
),	O
and	O
exposed	O
to	O
the	O
primary	O
antibodies	O
against	O
ERK	B-GP
,	O
p	O
-	O
ERK	B-GP
(	O
both	O
from	O
Sigma	O
),	O
p	O
-	O
P38	B-GP
,	O
p	O
-	O
JNK	B-GP
and	O
phosphorylated	O
IkB	B-GP
-	O
P	O
,	O
respectively	O
(	O
all	O
three	O
from	O
Cell	O
signalling	O
,	O
Danvers	O
,	O
MA	O
).	O

Prior	O
to	O
exposure	O
to	O
the	O
secondary	O
IgG	B-GP
Peroxidase	B-GP
antibody	O
(	O
anti	O
-	O
mouse	B-OG
IgG	B-GP
for	O
ERK	B-GP
and	O
p	O
-	O
ERK	B-GP
,	O
anti	O
-	O
rabit	O
IgG	B-GP
for	O
p	O
-	O
P38	B-GP
,	O
p	O
-	O
JNK	B-GP
and	O
p	O
-	O
IkB	B-GP
,	O
(	O
Sigma	O
)	O
the	O
bands	O
were	O
visualized	O
by	O
enhanced	O
chemiluminescence	O
(	O
PerkinElmer	O
,	O
Waltham	O
,	O
MA	O
)	O
and	O
quantified	O
with	O
the	O
NIH	O
software	O
(	O
Scion	O
Image	O
).	O

Determination	O
of	O
the	O
NF	B-GP
-	I-GP
κB	I-GP
p65	B-GP
subunit	O
in	O
macrophages	O
nuclear	O
extracts	O

Macrophages	O
were	O
co	O
-	O
cultured	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
with	O
a	O
1	O
∶	O
5	O
ratio	O
and	O
incubated	O
with	O
FOS	O
(	O
5	O
mg	O
/	O
ml	O
)	O
or	O
inulin	O
(	O
5	O
mg	O
/	O
ml	O
).	O

After	O
1	O
h	O
,	O
nuclear	O
extracts	O
were	O
obtained	O
using	O
a	O
nuclear	O
extract	O
kit	O
(	O
Active	O
Motif	O
,	O
Belgium	O
)	O
and	O
NF	B-GP
-	I-GP
κB	I-GP
activation	O
was	O
determined	O
by	O
quantifying	O
the	O
p65	B-GP
component	O
using	O
a	O
TransAM	O
kit	O
following	O
the	O
protocols	O
recommended	O
by	O
the	O
manufacturers	O
(	O
Active	O
Motif	O
,	O
Belgium	O
).	O

Cytotoxicity	O
Assays	O

Measurement	O
of	O
P	B-OG
.	I-OG
aeruginosa	I-OG
induced	O
cytotoxicity	O
in	O
macrophages	O
:	O
Macrophages	O
were	O
incubated	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
with	O
a	O
ratio	O
of	O
1	O
∶	O
5	O
for	O
4	O
hours	O
and	O
the	O
percentage	O
of	O
cytotoxicity	O
was	O
determinate	O
using	O
cytotox	O
96	O
non	O
-	O
radioactive	O
cytotoxicity	O
assay	O
kit	O
following	O
the	O
protocols	O
recommended	O
by	O
the	O
manufacturers	O
(	O
Promega	O
)	O
which	O
evaluates	O
cytotoxicity	O
by	O
assessing	O
the	O
total	O
release	O
of	O
cytoplasmic	O
lactate	B-GP
dehydrogenase	I-GP
(	O
LDH	B-GP
),	O
by	O
the	O
calorimetric	O
detection	O
,	O
into	O
culture	O
medium	O
as	O
a	O
consequence	O
of	O
damaged	O
cell	O
membranes	O
[	O
74	O
].	O

Determination	O
of	O
exotoxin	B-GP
A	I-GP
concentration	O
in	O
rat	B-OG
IEC18	O
cells	O
infected	O
by	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	I-OG

IEC18	O
cells	O
were	O
cultured	O
in	O
6	O
well	O
plates	O
.	O

At	O
confluence	O
IEC18	O
cells	O
were	O
infected	O
with	O
P	B-OG
.	I-OG
aeruginosa	I-OG
at	O
a	O
ratio	O
of	O
5	O
bacterial	O
cells	O
per	O
eukaryotic	O
cell	O
in	O
the	O
absence	O
and	O
in	O
the	O
presence	O
of	O
5	O
mg	O
/	O
ml	O
FOS	O
or	O
inulin	O
.	O

Plates	O
containing	O
cells	O
were	O
washed	O
3	O
times	O
with	O
PBS	O
and	O
incubated	O
with	O
gentamicin	O
at	O
100	O
µg	O
/	O
ml	O
for	O
1	O
h	O
to	O
eliminate	O
bacteria	B-OG
.	O

Subsequently	O
,	O
plates	O
were	O
washed	O
3	O
times	O
with	O
PBS	O
prior	O
to	O
cell	O
collection	O
using	O
RIPA	O
buffer	O
[	O
25	O
mM	O
Tris	O
–	O
HCl	O
,	O
pH	O
7	O
.	O
2	O
,	O
150	O
mM	O
NaCl	O
,	O
0	O
.	O
1	O
%	O
sodium	O
deoxycholate	O
and	O
0	O
.	O
1	O
%	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)]	O
containing	O
a	O
protease	B-GP
inhibitor	O
cocktail	O
(	O
Sigma	O
).	O

Proteins	O
were	O
extracted	O
for	O
Western	O
blot	O
analysis	O
,	O
as	O
described	O
above	O
.	O

Western	O
blot	O
were	O
carried	O
out	O
as	O
outlined	O
above	O
using	O
the	O
Exotoxin	B-GP
A	I-GP
antibody	O
(	O
Sigma	O
)	O
at	O
a	O
1	O
∶	O
2	O
.	O
000	O
dilution	O
.	O

Following	O
overnight	O
incubation	O
with	O
the	O
primary	O
antibody	O
the	O
membrane	O
was	O
incubated	O
with	O
the	O
secondary	O
IgG	B-GP
Peroxidase	B-GP
anti	O
-	O
rabbit	B-OG
antibody	O
(	O
Sigma	O
)	O
at	O
a	O
1	O
∶	O
3	O
.	O
000	O
dilution	O
for	O
two	O
hours	O
.	O

The	O
bands	O
were	O
detected	O
by	O
enhanced	O
chemiluminescence	O
(	O
PerkinElmer	O
,	O
Waltham	O
,	O
MA	O
)	O
and	O
quantified	O
with	O
NIH	O
software	O
(	O
Scion	O
Image	O
).	O

Statistical	O
analysis	O

All	O
results	O
are	O
expressed	O
as	O
means	O
with	O
the	O
corresponding	O
standard	O
deviations	O
.	O

Differences	O
among	O
means	O
were	O
analysed	O
for	O
statistical	O
significance	O
by	O
a	O
one	O
-	O
way	O
ANOVA	O
analysis	O
and	O
a	O
posteriori	O
least	O
significance	O
test	O
.	O

All	O
analyses	O
were	O
carried	O
out	O
using	O
the	O
SigmaStat	O
2	O
.	O
03	O
program	O
(	O
Jandel	O
Corporation	O
,	O
San	O
Rafael	O
,	O
CA	O
).	O

Concentration	O
-	O
response	O
curves	O
were	O
fitted	O
to	O
a	O
logarithmic	O
curve	O
when	O
possible	O
with	O
Origin	O
7	O
.	O
0	O
(	O
OriginLab	O
Corporation	O
,	O
Northampton	O
,	O
MA	O
).	O

Differences	O
were	O
considered	O
significant	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Supporting	O
Information	O

The	O
OD	O
at	O
560	O
nm	O
of	O
crystal	O
violet	O
(	O
CV	O
)	O
stained	O
and	O
resuspended	O
bacteria	B-OG
from	O
biofilm	O
are	O
given	O
.	O
Shown	O
are	O
means	O
and	O
standard	O
deviations	O
with	O
n	O
=	O
3	O
–	O
6	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
WT	O
in	O
the	O
absence	O
of	O
inulin	O
or	O
FOS	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

The	O
densitometric	O
analysis	O
of	O
experiments	O
is	O
shown	O
in	O
Fig	O
.	O
2A	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Measurement	O
of	O
interleukin	O
-	O
6	O
secretion	O
of	O
macrophages	O
in	O
the	O
presence	O
of	O
WT	O
P	B-OG
.	I-OG
aeruginosa	I-OG
PAO1	B-OG
and	O
its	O
ptxS	B-GP
and	O
ptxR	B-GP
mutants	O
.	O
The	O
macrophage	O
/	O
bacteria	B-OG
ratio	O
was	O
of	O
1	O
∶	O
5	O
.	O

Experimental	O
conditions	O
involving	O
incubation	O
for	O
4	O
hours	O
were	O
subsequently	O
used	O
to	O
assess	O
the	O
effect	O
of	O
FOS	O
and	O
inulin	O
on	O
interleukin	O
secretion	O
as	O
reported	O
in	O
Fig	O
.	O
4	O
and	O
7	O
.	O

Values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.,	O
n	O
=	O
3	O
;	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
without	O
bacteria	B-OG
and	O
&	O
P	O
<	O
0	O
.	O
05	O
vs	O
macrophage	O
with	O
WT	O
(	O
ANOVA	O
followed	O
by	O
least	O
significance	O
tests	O
).	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

